Efficacy of Combined Therapy With Silodosin and Solifenacin in Females With Overactive Bladder
Combining silodosin with solifenacin significantly improved OAB symptoms and QoL in females. This combination therapy was particularly effective in reducing postvoid residual volume compared to solifenacin alone. These findings suggest that adding an alpha-blocker to antimuscarinic therapy can enhance OAB management and patient satisfaction.
Authors
- Bum Sik Tae (ORCID: https://orcid.org/0000-0003-2963-7366)
- Jae Hyun Bae (ORCID: https://orcid.org/0000-0001-9862-3545)
- Jae Young Park (ORCID: https://orcid.org/0000-0002-6664-6846)
- Duck Ki Yoon
- Hyun Kyung Chang (ORCID: https://orcid.org/0000-0003-3723-1630)
- Byeong Jo Jeon
Institutions
- Korea University (KR)
Publication Details
- Journal
- International Neurourology Journal
- Published
- 2024-12-27
- DOI
- https://doi.org/10.5213/inj.2448374.187
- Citations
- 2
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 1.07
Funders
- Korea University